글로벌 합성 생물학 플랫폼 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 합성 생물학 플랫폼 시장

Data Bridge Market Research는 합성생물학 플랫폼 시장이 2021-2028년 예측 기간 동안 약 21.9%의 CAGR을 보일 것으로 분석했습니다. 합성 유전자와 세포에 대한 수요 증가는 합성생물학 플랫폼 시장의 성장을 촉진할 것입니다.

합성생물학은 새로운 능력을 개발하도록 유기체를 엔지니어링하여 재설계하는 과학 분야입니다. 합성생물학은 생명공학, 전기 및 컴퓨터 공학, 분자 공학, 생물물리학, 진화생물학 및 유전공학의 조합입니다. 제조, 의학 및 농업의 문제를 해결하는 데 사용됩니다.

합성 생물학에 대한 연구 및 개발 활동이 증가함에 따라 합성 생물학 플랫폼 시장에 수익성 있는 성장 기회가 창출될 것입니다. 약물 발견 및 합성 생물학 제품에 대한 정부의 지출 증가도 합성 생물학 플랫폼 시장의 성장을 촉진할 것입니다. 제약 회사의 합성 생물학 플랫폼에 대한 수요와 응용이 증가함에 따라 다시 시장 성장이 촉진되고 있습니다.

그러나 환경 및 안전에 대한 우려가 증가하면서 시장 성장률이 탈선될 것입니다. 저소득 및 중산층 경제에서 적절한 기술 인프라와 숙련 인력이 부족하면 시장 성장에 어려움이 따를 것입니다. 생물학적 부분의 수준이 상승하면 시장 성장 범위가 제한될 것입니다.

이 합성 생물학 플랫폼 시장 보고서는 최근의 새로운 개발, 무역 규정, 수입 수출 분석, 생산 분석, 가치 사슬 최적화, 시장 점유율, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 전략적 시장 성장 분석, 시장 규모, 범주 시장 성장, 응용 분야 틈새 시장 및 지배력, 제품 승인, 제품 출시, 지리적 확장, 시장의 기술 혁신에 대한 분석 기회를 제공합니다. Data Bridge Market Research 합성 생물학 플랫폼 시장에 대한 자세한 정보를 얻으려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 시장 성장을 달성하기 위한 정보에 입각한 시장 결정을 내리는 데 도움을 드릴 것입니다.

글로벌 합성 생물학 플랫폼 시장 범위 및 시장 규모

The synthetic biology platforms market is segmented on the basis of tool and technology, applications and product. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of tool and technology, the synthetic biology platforms market is segmented into tool and technology. Tool segment is further segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms and xeno-nucleic acids. Technology is further segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modelling, microfluidics, nanotechnology and computational modelling.
• On the basis of applications, the synthetic biology platforms market is segmented into medical applications, industrial applications, food and agriculture and environmental applications. Medical applications segment is further segmented into pharmaceuticals, drug discovery and therapeutics and artificial tissue and tissue regeneration. Industrial applications segment is sub-segmented into, biofuel and renewable energy, biomaterials and green chemicals and industrial enzymes. Environmental applications are also further segmented into bioremediation and bio sensing.
• On the basis of product, the synthetic biology platforms market is segmented into core product and enabling product. Core product is further segmented into synthetic DNA, synthetic genes, synthetic cells, XNA (Xeno nucleic acid) and chassis organisms. Enabling product is further segmented into DNA synthesis and oligonucleotide synthesis.

Synthetic Biology Platforms Market Country Level Analysis

The synthetic biology platforms market is analysed and market size insights and trends are provided by country, tool and technology, applications and product as referenced above.

The countries covered in the synthetic biology platforms market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the synthetic biology platforms market owing to the prevalence of advanced healthcare technology and rising awareness among the consumers. Upsurge in demand for synthetic biology platforms by pharmaceutical and biopharmaceutical companies will again propel the market growth in this region. Asia-Pacific region is expected to undergo the highest growth rate during the forecast period. This signifies that the region will score highest compound annual growth rate (CAGR) for the forecast period. This is because of the ever-rising geriatric population coupled with rising prevalence of chronic diseases. Rising public and private expenditure to improve the healthcare infrastructure will create lucrative growth opportunities for the synthetic biology platforms market in this region.

The country section of the synthetic biology platforms market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Synthetic biology platforms market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the synthetic biology platforms market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Synthetic Biology Platforms Market Share Analysis

The synthetic biology platforms market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to synthetic biology platforms market.

합성 생물학 플랫폼 시장 보고서에서 다루는 주요 기업으로는 Thermo Fisher Scientific Inc., Merck KGaA, Novozymes, Agilent Technologies, Inc., Precigen., GenScript, Twist Bioscience., Synthetic Genomics Inc., Codexis., Synthego, Eurofins Scientific, ATUM, TeselaGen., Integrated DNA Technologies, Inc., New England Biolabs., Igenbio, Inc., Bristol-Myers Squibb Company, Amyris, Ginkgo Bioworks, Integrated DNA Technologies, Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-36838